Detailed View
BIIB - Biogen Inc.
Latest filing: 2026-09-30 | Reporting: gaap
Market Cap
36,903,317,504
Adj EBIT (TTM)
1,940,100,000
Enterprise Value
35,599,417,504
Last Price
249.65
Earnings Yield
5.45%
Return on Capital
24.93%
Capital
7,783,200,000
1Y Price Chart
Last Price: $249.65
1Y Change: 67.40%
As of 2026-10-29 | 1Y Change: 67.40%
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-09-30 | 10-Q | 2026 | 2,804,100,000 | 77,800,000 |
| 2026-06-30 | 10-Q | 2026 | 2,736,000,000 | 68,800,000 |
| 2026-03-31 | 10-Q | 2026 | 2,477,800,000 | 74,200,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 2,279,400,000 | 1,072,600,000 |
| 2025-09-30 | 10-Q | 2025 | 2,534,700,000 | 87,200,000 |
| 2025-06-30 | 10-Q | 2025 | 2,645,500,000 | 75,000,000 |
| 2025-03-31 | 10-Q | 2025 | 2,431,000,000 | 58,100,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 2,454,700,000 | 658,900,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.